IBS Agent Tegaserod (Zelnorm) Is Pulled From Market

March 30, 2007
source: medpagetoday.com

ROCKVILLE, Md. -- The FDA announced today that Novartis has agreed to withdraw Zelnorm (tegaserod), the only approved drug for irritable bowel syndrome (constipation), after a pooled analysis of 29 placebo-controlled, short-term trials found a small but statistically significant increase in ischemic events, including angina and stroke. The analysis identifed 13 such events, including one death, in more than 11,600 patients treated with tegaserod versus one event among a placebo group.

If you're one of the many Americans taking Zelnorm, you know that stopping it will likely mean an immediate return of your symptoms -- what can you do now? Ashley Koff RD helps patients with constipation dominant IBS find relief from their symptoms through dietary, nutrient supplementation, and behavior modifications. In-person and phone appointments available.

"I was amazed at how well even my most difficult IBS patients did under the care of Ashley Koff RD"
- Mitchell J. Spirt MD Chief of Gastroenterology, Century City Doctors Hospital, and Associate Clinical Professor of Medicine, UCLA